<?xml version="1.0" encoding="UTF-8"?>
<p>Candidate drugs against COVID-19 include neuraminidase inhibitors such as Oseltamivir and Peramivir, anti-retroviral protease inhibitors like Ritonavir/Lopinavir, nucleotide analogs as Remdesivir, nucleoside inhibitors as Ribavirin, influenza hemagglutinin-mediated fusion inhibitors like Arbidol/Umifenovir and anti-malarials as Chloroquine, among others. </p>
